StemCells News

An overview of stock market chart and market dynamics to encourage investors and traders to be all they can be.

Today's economic data failed to rally the markets as it appears that some buying exhaustion is once again entering the fray.

StemCells, Inc. announced today that it welcomes the approval yesterday by the National Institutes of Health of the first 13 human embryonic stem cell lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009.

In this file photo originally made available by Advanced Cell Technology in 2006, a single cell is removed from a human embryo to be used in generating embryonic stem cells for scientific research.

Several stocks trading near $5 were moving on above-average volume during Wednesday's session.

As of Oct. 19, 2009, Fi... NEW YORK-- --Betawave , the online media network that delivers highly attentive audiences to brand marketers, today announced the appointment of Mark Oltarsh, former Vice Pre... PALO ALTO, Calif.-- --StemCells, Inc.

Xtremepicks.com Alerts include I.D. Systems, Inc. , iPCS, Inc. , StemCells, Inc.

On this day, we have begun tracking the following companies as they have shown remarkable correction in recent days, you can access these free reports with a number of other reviews by signing up for your complimentary membership at : http://www.rothmanresearch.com/ Companies been researched today are: Sigma Designs Inc.

StemCells Inc. filed Quarterly Report for the period ended 2009-09-30. Stemcells Inc.

NORTH BILLERICA, Mass.-- --BTU International, Inc. , a leading supplier of advanced thermal processing equipment and processes for the alternative energy and electronics as... NEW YORK-- --Genpact , a leader in the globalization of services and technology and a pioneer in managing business processes for companies around the world, today announced ...

Sea Transportation Partners announced an operating loss for the third quarter, hurt by asset impairment charges.

StemCells shares tumbled Wednesday on above-average volume after the biotech company announced it intends to sell 10 million shares of common stock.

Drug stocks were mixed in trading midday Wednesday as shares of Illumina Inc. plunged after a weaker-than-expected third-quarter earnings report.

StemCells, Inc. announced today new preclinical data showing that its human neural stem cells protect cone photoreceptors in the eye from progressive degeneration and preserve visual function long term.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

StemCells, Inc. announced organizational initiatives focused on growing its specialty SC Proven cell culture product business and advancing the development and commercialization of its central nervous system cell-based assay platforms for use in drug screening and drug development.

Individual stocks can surge 10%, 25%, or even higher in a short period of time. And they can fall just as far, just as quickly.

StockPreacher.com announces an investment report featuring biotechnology company StemCells Inc.

At the UCSF stem cell building topping off : Chancellor Susan Desmond-Hellmann; associate vice chancellor Barbara French; project manager Michael Toporkoff; and Rik Derynck, co-director of UCSF's stem cell research center.

StemCells, Inc. announced today that it will soon initiate with the University of California, San Francisco Childrena s Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCellsa proprietary HuCNS-SC A product candidate to treat Pelizaeus-Merzbacher Disease , a myelination disorder that primarily affects infants and young ...